Aperio Group, LLC - THERAVANCE INC ownership

THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 151 filers reported holding THERAVANCE INC in Q4 2013. The put-call ratio across all filers is 0.69 and the average weighting 0.4%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of THERAVANCE INC
ValueSharesWeighting
Q4 2015$166,000
+62.7%
15,721
+10.2%
0.00%
+100.0%
Q3 2015$102,000
-57.7%
14,270
+7.2%
0.00%
-50.0%
Q2 2015$241,000
+51.6%
13,312
+31.9%
0.00%0.0%
Q1 2015$159,000
-31.5%
10,095
+29.5%
0.00%
-33.3%
Q2 2014$232,000
+14.3%
7,796
+57.1%
0.00%
-25.0%
Q3 2013$203,0004,9630.00%
Other shareholders
THERAVANCE INC shareholders Q4 2013
NameSharesValueWeighting ↓
Baupost Group 20,144,301$718,144,00020.35%
Litespeed Management, L.L.C. 1,636,994$58,359,0008.44%
Realm Partners LLC 240,794$8,585,0007.27%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 2,828,059$100,820,0004.97%
IRIDIAN ASSET MANAGEMENT LLC/CT 7,456,503$265,824,0003.15%
SECTORAL ASSET MANAGEMENT INC 1,973,188$70,344,0003.03%
Foundation Asset Management, LP 221,796$7,907,0002.06%
Rhenman & Partners Asset Management AB 132,000$4,706,0001.84%
BB BIOTECH AG 888,244$31,666,0001.69%
HealthCor Management, L.P. 725,000$25,846,0001.57%
View complete list of THERAVANCE INC shareholders